Catatan bukti metode

Matched Phase IV Study

A Matched Phase IV study is a post-marketing observational design in which patients who received an approved drug (or intervention) are matched to comparable non-exposed patients — or patients on an alternative therapy — to evaluate real-world safety, effectiveness, or long-term outcomes. Conducted after regulatory approval, it combines the epidemiological rigour of matching with the breadth of post-authorization pharmacovigilance, generating evidence that randomized trials are rarely powered or timed to provide.

Sources recorded, not reviewed

Catatan sumber

Kutipan disalin apa adanya dari catatan sumber metode. Tidak ada verifikasi tingkat klaim yang disimpulkan darinya.

Matched Phase IV Post-Marketing Study

Catatan metode taksonomi · process-pipeline / epidemiology

Strom, B. L., & Kimmel, S. E. (Eds.). (2005). Textbook of Pharmacoepidemiology. Wiley. · ISBN 978-0470029244
Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. · DOI 10.1093/biomet/70.1.41

Buka metode lengkap

Klaim yang dikurasi

Klaim tersimpan dalam buku besar bukti, masing-masing dengan penilaiannya sendiri.

Belum ada klaim yang dikurasi

Tampilan ini tidak menciptakan penilaian klaim ketika buku besar tidak memilikinya.

Metode terkait

Dihasilkan dari grafik metode dan ditampilkan sebagai relasi yang disarankan mesin — tidak ada klaim bukti yang disimpulkan.

Taxonomic bucketCase-control studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.See alsoInterrupted Time Seriesmachine-suggested · Relational suggestion, not evidence.See alsoInverse Probability Weightingmachine-suggested · Relational suggestion, not evidence.Same method familyPropensity Score Matchingmachine-suggested · Relational suggestion, not evidence.